Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-10-05 08:42 |
PHARMING AND SWEDISH ORPHAN ANNOUNCE PUBLICATION OF RANDOMIZED CLINICAL TRIAL R…
|
Swedish | 151.5 KB | ||
| 2010-10-01 15:48 |
Pharming shareholders appoint Karl Keegan as CFO
|
English | 71.6 KB | ||
| 2010-09-13 08:37 |
Pharming signs commercialization agreement with Santarus for Rhucin® in North A…
|
English | 85.0 KB | ||
| 2010-09-02 08:32 |
Pharming clears 2010 private bond debt
|
English | 73.9 KB | ||
| 2010-08-25 15:44 |
Pharming plans submission Rhucin BLA to US FDA end 2010
|
English | 76.0 KB | ||
| 2010-08-25 09:08 |
Pharming provides update on outstanding shares
|
English | 84.2 KB | ||
| 2010-08-19 08:45 |
Pharming's Supervisory Board Nominates CFO
|
English | 75.4 KB | ||
| 2010-08-18 08:19 |
PHARMING PROVIDES UPDATE ON OUTSTANDING SHARES
|
English | 71.7 KB | ||
| 2010-08-06 07:33 |
Pharming provides update on outstanding shares
|
English | 71.8 KB | ||
| 2010-07-21 08:03 |
Pharming publishes financial report first half year 2010
|
English | 190.7 KB | ||
| 2010-07-21 07:08 | English | 190.7 KB | |||
| 2010-07-19 15:28 |
Pharming completes spin-off of DNage
|
English | 72.4 KB | ||
| 2010-07-12 18:06 |
Pharming provides update on outstanding shares
|
English | 67.8 KB | ||
| 2010-07-06 16:31 |
Pharming and Sanofi Chimie sign manufacturing agreement for the drug substance …
|
English | 86.9 KB | ||
| 2010-06-30 08:03 |
Pharming provides update on outstanding shares
|
English | 67.9 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
